ArticleThe Journal of clinical investigation2013

von Willebrand factor mutation promotes thrombocytopathy by inhibiting integrin αIIbβ3.

Caterina Casari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.